🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of efficacy and safety of 0.5 mg ranibizumab in Chinese patients with...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-11-05
Trial ID
NCT02259088
Treatments Being Tested
The primary objective of the study was to investigate current criteria driv...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-06-10
Trial ID
NCT02034006
Treatments Being Tested
This study will assess the efficacy and safety of ranibizumab (intravitreal...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT00901186
Treatments Being Tested
The study is intended to characterize the clinical benefit regarding safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05
Trial ID
NCT01580020
Treatments Being Tested
This study will evaluate efficacy and safety for monthly ranibizumab 0.5 mg...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-06
Trial ID
NCT00470678
Treatments Being Tested
Open-label Multicenter, Phase I/II Study comprising three phases (single do...
Status
Completed
Location
Novartis
Start Date
2005-04
Trial ID
NCT00284089
Treatments Being Tested
The purpose of this study was to assess the efficacy and safety of the anti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-11
Trial ID
NCT01594281
Treatments Being Tested
Provided efficacy and safety data on intravitreal injections of ranibizumab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11-12
Trial ID
NCT01976338
Treatments Being Tested